Individualizing Care of Patients with Type 2 Diabetes Using GLP-1 RAs: Education By Simulation

Using an interactive patient simulation platform, learners are guided through simulated cases to help them identify gaps in their care and improve their performance. Here’s what we learned from practitioners who utilized the platform to work through 2 type 2 diabetes cases related to glucagon-like peptide-1 (GLP-1) receptor agonists.

Share

Provided by

ProCE Banner

Supporters

Novo Nordisk